Martek Stock To Raise $11 Mil. For Plant Upgrades; Firm Files Patent Suit

Martek Biosciences' recent stock sale under a shelf registration statement is expected to bring in $11.2 mil. and allow the firm further breathing room to continue expanding its major manufacturing facilities

More from Archive

More from Pink Sheet